Abstract：Objective To compare the efficacy and safety of Itraconazole and Griseofulvin in the treatment of tinea capitis in children.Methods From January 2020 to January 2022,a total of 70 children with tinea capitis who were admitted to Jiujiang Third People's Hospital and Affiliated Hospital of Jiujiang University were selected as the research objects and divided into group A (35 cases,treated with Itraconazole) and group B (35 cases,treated with Griseofulvin)by random number table method.The clinical efficacy and fungal clearance rate of the two groups at the 4th,6th and 8th weeks of treatment were compared.The serum cystatin C (Cys-C),the improvement time of tinea capitis symptoms,retinol binding protein (RBP),adverse reactions and β2 microglobulin（β2-MG) level of the two groups were compared.Results After treatment,the levels of RBP and Cys-C in group A were lower than those in group B,and the differences were statistically significant (P＜0.05).There was no significant difference in β2-MG level between the two groups after treatment (P＞0.05).The improvement time of erythema,alopecia,yellow scab and pustule in group A were shorter than that in group B,and the total incidence of adverse reactions in group A was lower than that in group B,and the differences were statistically significant (P＜0.05).There were no significant differences in the fungal clearance rate and the total effective rate of clinical efficacy at the 4th,6th and 8th weeks of treatment between the two groups (P＞0.05).Conclusion The clinical efficacy of Itraconazole in the treatment of tinea capitis in children is consistent with Griseofulvin,but Itraconazole can effectively shorten the time for the improvement of clinical symptoms in children with lichen capitis and has higher drug safety.
涂盛安； 刘灵花； 周蜜. 伊曲康唑与灰黄霉素治疗儿童头癣的疗效及安全性观察[J]. 中国当代医药, 2022, 29(28): 62-65.
TU Sheng'an LIU Linghua ZHOU Mi. Efficacy and safety of Itraconazole and Griseofulvin in the treatment of tinea capitis in children. 中国当代医药, 2022, 29(28): 62-65.
Aspiroz C，Melcon B，Cerro PA，et al.Tinea capitis caused by Microsporum canis treated with methyl-aminolevulinate daylight photodynamic therapy and ketoconazole shampooing[J].Photodermatol Photoimmunol Photomed，2021，37（6）：567-568.
[3]
Xiao YY，Zhou YB，Chao JJ，et al.Successful treatment of tinea capitis caused by Microsporum canis in a 23-day-old newborn with itraconazole pulse therapy and a review of the literature[J].Dermatol Ther，2021，34（5）：e15078.
[4]
Woodard AA，Le TK，Dibiagio JR，et al.A Retrosp ective Study of Tinea Capitis Managem ent in General Pediatric Clinics and Pediatric Emergency Departments at 2 US Centers[J].J Pediatr，2021，234（1）：269-272.
Meneses O，Donati A，Silva FO，et al.Trichoscopy patterns of tinea capitis and their correlation with mycological culture results[J].J Am Acad Dermatol，2021：S0190-9622（21）02967-4.
[10]
Martínez Campayo N，Rego Campuzano I，González de Aledo M，et al.New Epidemiological Outcomes in Anthropophilic tinea capitis，a Case Series Study in Northwestern Spain[J].Actas Dermosifiliogr，2022，113（1）：74-77.
[11]
Ungo-Kore HY，Ehinmidu JO，Onaolapo JA，et at.Molecular Characterisation and Phylogenetic Analysis of Dermatophytic Fungi Isolated from Tinea Capitis in Northwest Nigeria Using Sequence of the 28S rRNA[J].Microbio Res，2021，12（3）：646-655.
Zhu L，Zhao R，Li Y，et al.CtD Strategy to Construct Stereochemically Complex and Structu-ally Diverse Compounds from Griseofulvin[J].Chem Commun（Camb），2021，57（82）：10755-10758.
Bhanderi A，Bari F，Al-Obaidi H.Evaluation of the impact of surfactants on miscibility of griseofulvin in spray dried amorphous solid dispersions[J].J Drug Deliv Sci Technol，2021，64（1）：102606.
[17]
Farinella VF，Kawafune ES，Tangerina MMP，et al.OSMAC Strategy Integrated with Molecular Networking for Accessing Griseofulvin Derivatives from Endophytic Fungi of Moquiniastrum polymorphum（Asteraceae）[J].Molecules.2021，26（23）：7316.
京公网安备 11010502046607号